Arix Bioscience (ARIX)

Company name:	Arix Bioscience Plc
EPIC:	ARIX	Trading Currency:	GBX
Market Sector:	SQS3	ISIN:	GB00BD045071
Market Segment:	SSQ3	Share Type:	DE
WWW Address:	https://arixbioscience.com/ipo-documents/	Description:	ORD 0.001P
Industry Sector:	PHARMACEUTICALS & BIOTECHNOLOGY

Arix Bioscience Key Figures

(at previous day's close)
Market Cap.	142.10	m
Shares In Issue	129.18	m
Prev. Close	109.50
PE Ratio	-
Dividend Yield	-	%
EPS - basic	-48.00	p
Dividend PS	-	p
Dividend Cover	-
Cash Flow PS	-5.53	p
Return On Equity (ROE)	-23.89	%
Operating Margin	-17,965.88	%
PEG Factor	-
EPS Growth Rate	-149.69	%
Dividends PS Growth Rate	-	%
Net Debt	-132.51	m
Gross Gearing	0.67	%
Quick Assets	136.07	m
Net Working Capital	134.47	m
Intangibles / Fixed Assets	0.14	%
Turnover PS	0.26	p
Pre-Tax Profit PS	-47.29	p
Retained Profit PS	-47.22	p
Cash PS	103.91	p
Net Cash PS	102.67	p
Net Tangible Asset Value PS *	197.54	p
Net Asset Value PS	197.67	p
Spread	2.00 (1.82%)
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Period ^†	Open	Change	%	Open Avg.	Avg. Daily Vol [m]	Total Vol [m]	VWAP
1 week	112.00	-2.00	-1.79	109.00	0.03		110.65
4 weeks	113.50	-3.50	-3.08	109.00	0.06		112.86
12 weeks	112.50	-2.50	-2.22	109.00	0.13		114.44
26 weeks	122.00	-12.00	-9.84	109.00	0.15		118.51
1 year	179.00	-69.00	-38.55	66.68	0.15		133.46
3 years	136.00	-26.00	-19.12	58.50	0.13		142.83
5 years	205.38	-95.38	-46.44	58.50	0.10		148.90
† periods calculated are whole weeks rather than calendar months

(Market value analysis) at previous day's close
PQ Ratio	-
PE Ratio	-
Tobin's Q Ratio	0.48
Tobin's Q Ratio (excl. intangibles)	0.48
Dividend Yield	-	%
Market-to-Book Ratio	0.56
Price-to-Pre-Tax Profit PS	-2.33
Price-to-Retained Profit PS	-2.33
Price-to-Cash Flow PS	-19.91
Price-to-Sales PS	417.94
Price-to-Net Tangible Asset Value PS	0.56
Price-to-Cash PS	1.06
Net Working Capital PS	104.09
Price Pct to Working Capital PS	1.06	%
Earnings Yield	-	%
Average PE	3.73
Years in average	2
PE to PE average	-	%

(Leverage Ratios)
Debt Ratio	0.05	%
Debt-to-Equity Ratio	0.00
Debt-to-Equity Ratio (excl. Intgbl)	0.00
Debt-to-Equity Market Value	0.00
Net Gearing	-51.54	%
Net Gearing (excl. Intangibles)	-51.58	%
Gross Gearing	0.67	%
Gross Gearing (excl. Intangibles)	0.67	%
Gearing Under 1 Year	0.62	%
Gearing Under 1 Year (excl. Intgbl)	0.62	%
Assets/Equity	1.01
Cash/Equity	52.57
(Liquidity Ratios)
Net Working Capital to Total Assets	52.31	%
Current Ratio	85.04
Quick Ratio (Acid Test)	85.04
Liquidity Ratio	83.89
Cash & Equiv/Current Assets	98.65	%
(Solvency Ratios)
Enterprise Value	7.99	m
CFO/Sales	-20.99
CFO/Attributable Profit	-
CFO/Assets	-0.03
CFO/Debt	-4.15
Total Debt/Equity Market Value	0.01
Total Debt/Sales	5.06
Total Debt/Pre-Tax Profit	-0.03
Total Debt	1.72	m
Total Debt/Net Current Assets	0.01	%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth	-3.73	%
5 yr Compound Earnings Growth	-	%
10 yr Compound Earnings Growth	-	%
Earn drops > 5% in 10yrs	2

Beta (60-Mnth)	Beta (36-Mnth)
0.0611	0.0400

(Profitability Ratios)
Return On Capital Employed (ROCE)	-23.91	%
Return On Assets (ROA)	-20.75	%
Net Profit Margin	-17,939.12	%
Assets Turnover	0.00
Return On Equity (ROE)	-23.89	%
Return On Investment (ROI)	-20.89	%
Dividend Payout Ratio	-	%
Plowback Ratio	100.00	%
Growth from Plowback Ratio	-	%
Net Income Of Revenues	-17,939.12	%
(Asset Utilisation Multiples)
Shareholders Equity Turnover	0.00
Fixed Assets Turnover	0.00
Current Assets Turnover	0.00
Net Working Capital Turnover
Inventory Turnover	-
(Other Operating Ratios)
Total Assets-to-Sales	864.40
Debtors-to-Sales	9,428.68	%
Debt Collection Period	34,414.67	Days

Sorry No Data Available

Broker infomation is not available for this class of stock.